Table 1.
Clinical findings and response to treatment with oral valacyclovir
| Patient | Age,Sex | Eye | Virus | Posterior extent (zone) | Time to initial response (weeks) | Time to complete resolution (weeks) | Initial BCVA | Final BCVA | Laser | Steroids | Complications |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 |
79, M |
R |
Undetermined |
1 |
1 |
5 |
20/200 |
20/40 |
No – Zone 1 |
OFSI |
RPE change at macula |
| 2 |
39, M |
L |
Presumed VZV |
3 |
1 |
1 |
20/20 |
20/20 |
No – Zone 1 |
No |
Nil |
| 3 |
82, M |
R |
VZV on PCR |
1 |
1 |
4 |
20/120 |
CFs |
Yes |
Oral prednisolone |
RD at 45 days |
| 4 |
54, F |
L |
VZV on PCR |
2 |
2 |
6 |
CFs |
20/60 |
Yes |
Oral prednisolone |
Nil |
| 5 |
36, M |
R |
HSV-2 on PCR |
2 |
1 |
3 |
20/30 |
20/80 |
Yes |
Oral prednisolone |
RD at 35 days |
| 6 |
36, M |
L |
Undetermined |
3 |
1 |
3 |
20/20 |
20/16 |
No |
No |
Nil |
| 7 |
33, M |
L |
Presumed HSV-1 |
1 |
2 |
5 |
HMs |
LP |
No – Zone 1 |
Oral prednisolone |
RD at 49 days |
| 8 |
30, F |
R |
Presumed VZV |
3 |
1 |
2 |
20/20 |
20/20 |
Yes |
No |
Nil |
| |
|
L |
Presumed VZV |
2 |
1 |
2 |
20/30 |
20/20 |
Yes |
No |
Nil |
| 9 | 81, M | L | Undetermined | 2 | 1 | 6 | 20/20 | 20/40 | Yes | Oral prednisolone | Nil |
VZV = Varicella zoster virus; HSV = Herpes simplex virus; PCR = polymerase chain reaction; BCVA = best corrected visual acuity; CFs = count fingers; HMs = hand movements; LP = perception of light; OFSI = Orbital floor corticosteroid injection; RD = retinal detachment.